Understanding how tumor evolution differs across ancestries to improve cancer treatment
Simulating Ancestrally Unbiased Tumor Evolution To Interrogate Drug Resistance
This study is looking at how tumors from cancer patients of different backgrounds behave differently and how that affects their treatment, especially for African-American men with prostate cancer, to help create better and more effective therapies for everyone.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10687776 on NIH RePORTER |
What this research studies
This research investigates the molecular differences in tumors among cancer patients of various ancestries, focusing on how these differences affect responses to therapies. By examining both genetic and non-genetic alterations, the study aims to develop better models for tumor evolution that are representative of diverse populations. The goal is to create therapies that are more effective for patients who are often underrepresented in current cancer research, particularly African-American prostate cancer patients who face higher risks of drug resistance and mortality.
Who could benefit from this research
Good fit: Ideal candidates for this research include cancer patients from diverse ancestral backgrounds, particularly those with prostate cancer.
Not a fit: Patients who do not have cancer or those whose tumors do not exhibit significant molecular differences based on ancestry may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer treatments tailored to the unique molecular profiles of diverse patient populations.
How similar studies have performed: Previous research has shown that understanding molecular differences in tumors can lead to significant advancements in personalized cancer therapies, suggesting this approach has potential for success.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Bose, Rohit — University of California, San Francisco
- Study coordinator: Bose, Rohit
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.